Stergios Moschos

Title: Stergios Moschos: Innovator in Cancer Treatment and Imaging

Introduction

Stergios Moschos is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment and imaging, holding a total of 2 patents. His work focuses on innovative methods that enhance the effectiveness of therapies for melanoma and improve imaging techniques.

Latest Patents

Moschos' latest patents include groundbreaking inventions such as "Methods for the Treatment of Melanoma Using Compositions of Denosumab and PD-1 Inhibitor." This patent outlines a novel approach to treating melanoma by combining specific therapeutic agents. Another notable patent is for "F-labeled Compounds for PET Imaging and Uses Thereof." This invention relates to F-labeled compounds that are suitable for positron emission tomography (PET) imaging. It further explores the use of these compounds for conducting PET scans, imaging the indoleamine 2,3-dioxygenase pathway, predicting the responsiveness of solid tumors to therapies, including immunotherapy, and determining the presence of tumor-infiltrating immune cells.

Career Highlights

Stergios Moschos is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in cancer therapies and imaging technologies. His work has garnered attention for its potential to improve patient outcomes in oncology.

Collaborations

Some of his notable coworkers include Zibo Li and Ben Giglio, who contribute to the collaborative efforts in research and development within the university.

Conclusion

Stergios Moschos is a key figure in the innovation of cancer treatment and imaging technologies. His patents reflect a commitment to advancing medical science and improving therapeutic strategies for patients.